Pier Vitale Nuzzo

20PUBLICATIONS
97CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 03, 2026
Suppression of de novo lipogenesis and dietary PUFA supplementation inhibit prostate cancer progression.

Silvia D Rodrigues, Caroline Fidalgo Ribeiro, Giuseppe N Fanelli

|Mar 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapy.

Sara Bleve, Francesco Ravera, Silvia Rodrigues

|Oct 09, 2025
Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy.

Sara Bleve, Pier Vitale Nuzzo, Abdul Baseet Arham

|Nov 09, 2024
Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component.

Hubert Pakula, Filippo Pederzoli, Giuseppe Nicolò Fanelli

|Sep 18, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.

Miklos Diossy, Viktoria Tisza, Hua Li

|Feb 10, 2024
Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring.

Edoardo Francini, Pier Vitale Nuzzo, Giuseppe Nicolò Fanelli

Pageof 4

Frequent Collaborators

9 joint publications

Amin H Nassar

8 joint publications

Toni K Choueiri

6 joint publications

Giuseppe Nicolo' Fanelli

5 joint publications

Ziad Bakouny